Where does Cellectar Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cellectar Biosciences, Inc. ranks #31,154 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cellectar Biosciences, Inc. hold?

Cellectar Biosciences, Inc. holds 8 US utility patents granted between 2016 and 2022, spanning 6 technology areas.

What is Cellectar Biosciences, Inc.'s Innovation Score?

Cellectar Biosciences, Inc. has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cellectar Biosciences, Inc.'s patent grant rate increasing or decreasing?

Cellectar Biosciences, Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cellectar Biosciences, Inc.'s patents?

Cellectar Biosciences, Inc.'s patents average 10.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cellectar Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cellectar Biosciences, Inc.

Q: What technology areas does Cellectar Biosciences, Inc. focus on?

Cellectar Biosciences, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cellectar ranks #31,154 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.

#31,154
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 10.9
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31154 · US Corporation #31,154 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,154/49,997
PHOTO-FINISH Ccys Hi-tech…
CPC-NARROW A61K · 6 areas
INNOV-THIN 36.1/100
CLAIMS-PAR 10.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ccys Hi-tech International Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cellectar Biosciences · this assignee

36
3D Lighting… · lowest

7

What this shows Cellectar's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cellectar's grants concentrate

Cellectar Biosciences, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 87.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Cellectar sits between Ccys Hi-tech International Ltd. and Centre Technique DE L'industrie DES Papiers, Cartons ET Celluloses.

Cellectar's three-year grant acceleration

Cellectar Biosciences, Inc. shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ccys Hi-tech Inte…

8
Cebi Electromecha…

8
Cell Cure Neurosc…

8
Cell Therapy Hold…

8
Cellscript

8
Celluforce

8
Centivax

8
Centre Technique…

8
Cellectar Bioscie… ◀

8

What this shows Cellectar holds 8 patents at rank #31,136, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cellectar

By rank, the assignees closest to #31,136 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Cellectar's primary technology class.

Cellectar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cellectar Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	25.0%
2017	3	37.5%
2018	1	12.5%
2022	2	25.0%

Which technologies does Cellectar Biosciences, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#31,154

of 49,997 tracked assignees

Innovation Score

36.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Cellectar Biosciences, Inc.'s patent record in context - here's where to go next.

Cellectar Biosciences, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 87.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #31,154 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cellectar Biosciences, Inc. against Ccys Hi-tech International Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.